Articles

Find an Article

Filter articles

Applied Filters

Showing 751 to 760 of 847 results

ANDA one, ANDA too?

US01-12-2010David K.S. Cornwell and Kevin W. McCabe

David Cornwell and Kevin McCabe describe the complex process for obtaining FDA approval for generic and biosimilar drugs, and managing patent disputes with approved companies.

Will the future of gene patents be "markedly different" after Myriad?

US01-12-2010BiotechnologyLee Crews and Vicki Norton

A US district court decision threatens the future of so-called ‘gene patents’ in the US. Lee Crews and Vicki Norton look at the current position and assess the possible futures for the case.

Counterfeit medicines - the quintessential borderless crime

01-12-2010

The global spread of counterfeit pharmaceuticals presents a formidable challenge to public health. WIPR asked lawyers from Baker & McKenzie offices around the world about this growing menace and what IP rights owners can do.

Towards an EU patent

EPO, EU01-12-2010

People have been talking about a single Europe-wide patent for more than 60 years, although political concerns always seem to get in the way. WIPR talks to four key stakeholders about what the future holds.

Stefan Krawczyk: eBay

01-12-2010

WIPR talks to eBay's head of the government relations team.

IP Summit, December 2-3, 2010: general highlights

01-12-2010

The organisers at Premier Cercle have managed to put together an outstanding programme of high-level conferences and workshops for the fourth pan-European Intellectual Property Summit since 2004.

Local knowledge

01-12-2010

The 4th Pan-European Intellectual Property Summit will take place at Plaza Hotel, Blvd Adolphe Max 118-126 in Brussels, on December 2 and 3, 2010.

France catches up

France01-12-2010

The European Patent Convention 2000 introduced new provisions enabling a patentee to limit the claims of its patent, even though the patent has been definitively granted. Now similar provisions have been introduced into French law.

Taking the next step in brand and patent security

US01-12-2010Dean Hart

While pharmaceutical companies suffer greatly from the counterfeit drugs trade, it is important to remember that, ultimately, it is patients who suffer the most. Dean Hart explains.

Prepare for a clash of IP cultures

01-12-2010Gary Johnson

Consumer-grade medical devices are growing in popularity across the developed world in response to lifestyle-related health problems and an increased demand for personal influence over medical decisions.

Showing 751 to 760 of 847 results

Directory

Service Providers

Batavia Patentservis Asia (formerly Batavia Patent Agent)
Indonesia

Park IP Translations
Park IP is your trusted partner for legal language solutions

TrademarkNow
Trademark Research Tools & Watching Services, Watching Services

Practice Insight
Get the Information Edge with Practice Insight

WIPR